Fairvalue-Calculator Fairvalue-Calculator
EN DE

Peptron, Inc (087010) Fair Value & Analysis

Healthcare · KR · Market cap 5.9T KRW

Price216,000 KRW
Fair Value41,695 KRW
Upside-80.7%
Quality95/100
Evidence: Low Range 31,271 KRW – 52,119 KRW

Analysis

Peptron, Inc (087010) currently trades at 216,000 KRW, while our model-based Fair Value estimate is 41,695 KRW — implying the stock looks roughly 80.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.

Open the full interactive analysis →

Similar stocks

MEDIPOST Co (078160) +172% Bioneer Corporation (064550) -58% Macrogen, Inc (038290) -27% Cell Biotech Co (049960) +28% Panagene Inc (046210) +15% Biotoxtech Co (086040) -16%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.